Several companies are allegedly involved in the manufacturing of Abacavir Sulphate, identified by the API number 188062-50-2, within the capital of Afghanistan . Though the presence of these concerns, verifiable details regarding their capacity and adherence to international regulatory standards remain difficult to ascertain. The local pharmaceutic